nuciferine has been researched along with Disbacteriosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Gao, P; He, Z; Huang, P; Lin, Q; Liu, S; Luo, M; Luo, T; Tang, Z; Wang, X; Zhu, J | 1 |
Gong, S; Li, B; Liu, M; Qian, S; Wang, J; Wang, Y; Wei, B; Wei, M; Yao, W | 1 |
2 other study(ies) available for nuciferine and Disbacteriosis
Article | Year |
---|---|
Nuciferine administration in C57BL/6J mice with gestational diabetes mellitus induced by a high-fat diet: the improvement of glycolipid disorders and intestinal dysbacteriosis.
Topics: Animals; Aporphines; Diabetes, Gestational; Diet, High-Fat; Dysbiosis; Female; Gastrointestinal Microbiome; Glycolipids; Lipid Metabolism; Liver; Mice; Mice, Inbred C57BL; Pregnancy | 2021 |
Nuciferine modulates the gut microbiota and prevents obesity in high-fat diet-fed rats.
Topics: Animals; Aporphines; Diet, High-Fat; Dose-Response Relationship, Drug; Dysbiosis; Fatty Acids; Gastrointestinal Microbiome; Lipid Metabolism; Metabolome; Metabolomics; Metagenome; Metagenomics; Obesity; Protective Agents; Rats | 2020 |